Antibodies to the disulfide knot fragment of bovine fibrinogen have been used to locate the site of this fragment within the intact fibrinogen molecule. The antibodies were isolated from rabbit antifibrinogen antisera by affinity chromatography. Electron micrographs of reaction mixtures of bovine fibrinogen and antibodies against the disulfide knot fragment showed pairs of fibrinogen molecules crosslinked by antibody molecules as well as higher order antibody-fibrinogen complexes. From an electron microscopic investigation of the crosslinked material, we conclude that the disulfide knot lies within the central nodule of the trinodular fibrinogen molecule. Antibodies to fragment H were used in the same manner to locate this fragment within the outer nodules of the human fibrinogen molecule.
brinogen molecule.
In connection with our studies of the interaction of thrombin with fibrinogen (1, 2) and of the polymerization of fibrin monomer (3, 4) , it is important to locate the sites of the fibrinogen molecule that are involved in various functions such as thrombin-binding, polymerization, fibrin stabilization, and plasmin degradation. From a series of physicochemical (5, 6) and electron microscopic (4, (7) (8) (9) (10) observations, the linear trinodular structure of fibrinogen appears established. In addition, electron microscope observations of dimers, trimers, tetramers, etc. of fibrin monomer (4) have verified the conclusions from earlier physicochemical studies (11) that these intermediate polymers arise by a lateral association with partial overlapping, giving two parallel end-to-end chains with staggered junctions. In this paper, we use the technique of immunoelectron microscopy (12) (13) (14) (15) (16) to locate two peptide fragments within the trinodular structure of fibrinogen. These two fragments are the "disulfide knot" (N-DSK) (17) and fragment H (18) . The former is the disulfide-linked NH2-terminal portions of the Aa, Bf3, and -y chains (Mr -58,000) produced by CNBr cleavage of fibrinogen (17) , and fragment H (Mr 20,000) is a plasmin-digestion product of fibrinogen (18) . By comparison of the NH2-terminal sequence of fragment H given by Harfenist and Canfield (18) with the amino acid sequence reported by Doolittle et al. (19) , it appears that fragment H corresponds to residues 240-424 of the Aa chain.
MATERIALS AND METHODS
Bovine fibrinogen (96% clottable) was prepared from Miles fraction I (lot 90, 75% clottable) or Sigma fraction I (lot 117C-0140, 82% clottable) as described (20) and was dialyzed against 10 mM Na2HPO4/3 mM KH2PO4/120 mM NaCl, pH 7.5 (phosphate-buffered saline), 5 mM H3B04/1.25 mM Na2B4O7.10H20/140 mM NaCl, pH 8.5 (borate/saline buffer), or 50 mM ammonium formate (pH 8.5) for immunization, quantitative precipitation, or electron microscopy, respectively. The reduced and alkylated material exhibited three bands (corresponding to the Aa, BB, and y chains) on NaDodSO4/ 7.5% polyacrylamide gel electrophoresis (21) . All other chemicals were of reagent grade or better.
Human fibrinogen was purchased from AB Kabi (Stockholm, lot 1981-07-01-57031, grade L, 95% clottable). It was dissolved in 50 mM ammonium formate (pH 8.5) and dialyzed overnight at 4°C against this salt solution.
Fibrinogen concentrations were determined from the absorbance at 280 nm with an extinction coefficient of 1.6 ml mg'-cm-1 (22) . The concentrations of DSK and rabbit IgG were determined in the same manner, with extinction coefficients of 1.18 (23) and 1.67 ml mg-' cm-1 (24), respectively. Clottability was measured by the method of Laki and Gladner (25) .
The disulfide knot (DSK), which represents approximately 16% of the entire molecule and contains the sections of the Aca and B#. chains from which fibrinopeptides A and B are hydrolyzed by the action of thrombin, was first prepared from human fibrinogen by Blomback et al. (17) . Their procedure, as modified by Hageman and Scheraga (20) , was used (with one additional modification) to obtain the DSK of bovine fibrinogen. The Sephadex G-100 column, used previously, was replaced by a Sephacryl S-200 Superfine (Pharmacia) column (5.5 X 100 cm) equilibrated with 0.1 M ammonium acetate buffer (pH 3.5). The column was eluted at a flow rate of 60 ml/hr, and 15-min fractions were collected.
Fragment H, a polypeptide that arises early in the digestion of human fibrinogen by plasmin, was isolated and characterized by Harfenist and Canfield (18) . Edman degradation showed that it consists mainly of a single polypeptide chain whose NH2-terminal sequence is Met-Glu-Leu-Glu-Arg-ProGly-Gly-Asn-Glu-, with a minor contaminating subfragment beginning at residue 254 (18 (27) ; they were dissolved in and dialyzed against borate/saline buffer and stored in small volumes at -20'C.
The IgG fraction of the antisera (20-50 ml) was passed through the fibrinogen affinity column at room temperature at a flow rate of 20 ml/hr, and 2-ml fractions were collected. The column was washed with 50 ml of borate/saline buffer, 15 ml of 0.1 M sodium acetate/0.5 M NaCI, pH 5.5, and 10 ml of 0.5 M NaCI, pH 5.5 Anti-DSK was prepared by passing 42 ml of antifibrinogen (0.8 mg/ml) through the DSK-affinity column by the same procedure as above. The anti-DSK was dialyzed against 50 mM ammonium formate (pH 8.5) for electron microscopy.
Double immunodiffusion according to Ouchterlony (30) was performed on 0.9% agarose immunodiffusion discs (Miles). Protein samples were in borate/saline buffer, phosphate-buffered saline, or ammonium formate. Whole antifibrinogen antiserum was also analyzed by the quantitative precipitation method described previously (27) .
Antiserum against fragment H was prepared by Canfield and coworkers, and kindly provided to us as a frozen solution. The antiserum had been prepared by immunizing rabbits with a fragment H-ovalbumin conjugate. The frozen solution was thawed, and the IgG fraction was obtained by ammonium sulfate precipitation as described (27) . The IgG fraction was dissolved in ammonium formate and dialyzed against this buffer.
Antigen-antibody complexes were prepared for electron microscopy in the following manner. Complexes of bovine fibrinogen with anti-DSK were formed by adding 400 Al of bovine fibrinogen (1.7 mg/ml) to 120 ul of anti-DSK antibodies (0.25 mg/ml), both in ammonium formate, and incubating at 37°C for 30 min (this is a 10:1 molar ratio of fibrinogen to anti-DSK antibody).
Human fibrinogen (0.5 ml, 0.4 mg/ml) was incubated with 0.5 ml of the IgG fraction of the rabbit serum containing antibodies against fragment H (0.7 mg/ml) for 30 minat Chemistry: Telford et A Nonspecific IgG appeared in the first large peak. The material from tubes 39-51 (containing anti-fibrinogen antibodies) was pooled, dialyzed against borate/saline buffer, passed through a Millipore filter, and applied to the DSK affinity column. The isolated anti-DSK antibodies represented ;30% of the antifibrinogen antibodies that were added to the DSK affinity column.
Immunodiffusion. Fig. 2 illustrates a double-immunodiffusion experiment with several different proteins. Antifibrinogen serum gave rise to a strong precipitin line against bovine fibrinogen and a weak precipitin line against DSK. Antifibrinogen antibodies (from tubes 39-51 of Fig. 1 ), dialyzed against ammonium formate, showed a strong diffuse precipitin line against bovine fibrinogen. Anti-DSK antibodies gave a sharp precipitin line against bovine fibrinogen and a weak line against DSK. Control serum showed no precipitin line with either bovine fibrinogen or with DSK. Purified antifibrinogen did not appear to give a precipitin line against DSK. With a higher concentration of DSK (12 mg/ml) and a 10-fold increase in the concentration of anti-fibrinogen in other experiments, however, precipitin lines were visible against antifibrinogen.
Quantitative Precipitation Analysis. These analyses, with whole anti-bovine fibrinogen antiserum, were carried out, as in ref. 27 , to determine the number of antibodies bound per fibrinogen molecule. By using an average Mr of 150,000 for antibody molecules and one of 340,000 for fibrinogen, a value of 35 for the minimum molar ratio of antibody to fibrinogen was obtained. This represents a minimum value for the number of antibodies bound per fibrinogen molecule because some antigenic determinants could overlap or lie close to each other (i.e., by competition or steric hindrance between antibody molecules of different specificities, the binding of one antibody could prevent the binding of another). Thus, there are _035 antigenic sites per fibrinogen molecule.
Electron Microscopy of Bovine Fibrinogen. Center well, DSK (25 AI, 10 mg/ml in phosphate-buffered saline); 1 and 4, bovine fibrinogen (25 AI, 1.7 mg/ml in borate/saline buffer); 2, purified anti-bovine fibrinogen (25 AI, 0.5 mg/ml in borate/saline buffer); 3, anti-bovine fibrinogen antiserum (25 Al); 5, normal rabbit serum (control; 25 gl); 6, anti-DSK (25 Al, 0.6 mg/ml in ammonium formate). Although no precipitin line is visible between 2 and the center well, it was visible in other immunodiffusion experiments with a 10-fold increase in purified antifibrinogen concentration. distributed randomly over the whole area. The individual molecules appear as trinodular rods. The structures of the molecules, dried in the presence of glycerol (10) Fig. 4a. Fig. 4b shows reaction mixtures of fibrinogen incubated with antibodies against fragment H, depicting several forms of fibrinogen-antibody complexes. Pairs of fibrinogen molecules, as well as higher-order complexes, interpreted as being crosslinked by anti-fragment H antibody molecules, may be observed in the gallery of Fig. 4c . In contrast to Fig. 3b, Fig.  4c shows that antibody against fragment -H crosslinks the fibrinogen molecule at the outer nodules.
Several facts indicate that fragment H must be near the surface of the fibrinogen molecule. (i) In physiological regulation of fibrinolysis, plasmin can attack fibrinogen and release fragment H quite readily (18, 35) ; (ii) this peptide is highly hydrophilic (18) ; and (iii) fragment H contains the crosslinking acceptor sites necessary for the in vivo stabilization of fibrin by Factor XIII (18, 36, 37) . These acceptor sites include residues 328 and 366 of the Aa chain (19, 37) . The immunoelectron microscopic evidence presented here is in agreement with the location of fragment H on the surface of the intact fibrinogen molecule.
Conclusion. On the basis of the observations reported here, it appears that the bovine DSK (containing the NH2-terminal portions of the Aa, Bj3, and y chains, including the Arg-Gly bonds hydrolyzed by thrombin) is located in the central nodule of fibrinogen, and that human fragment H (consisting of residues 240-424 of the Aa chain) is located in the outer nodule.
Note Added in Proof. The thickness of the shell of platinum/palladium that surrounds the shadowed fibrinogen molecules has been calibrated with ferritin molecules of known diameter that had been rotary shadowed by the same procedure as used for the fibrinogen preparations. The thickness of the shell of platinum/palladium was found to be 25 ± 3 A. Therefore, the corrected dimensions of the fibrinogen molecule, reflecting the contribution of two thicknesses of a 25-A-thick platinum/palladium shell.surrounding each molecule, are: length, 445 A; diameter of outer nodules, 92 A; diameter of center nodule, 59 A.
